International Journal of Drug Policy
Volume 20, Issue 1 , Pages 85-89 , January 2009

Opioid dependent patients’ experiences of and attitudes towards having their injecting sites examined

  • Adam R. Winstock

      Affiliations

    • Drug Health Services, Sydney South West Area Health Service, Australia
    • National Drug and Alcohol Research Centre, University of New South Wales, Australia
    • Corresponding Author InformationCorresponding author at: Drug Health Services, Locked Bag 4002, Ashfield, NSW 2132, Australia. Tel.: +61 2 9378 1316; fax: +61 2 9378 1338.
    • ,
  • Maria Nittis

      Affiliations

    • Drug Health Services, Sydney South West Area Health Service, Australia
    • Tel.: +61 2 4634 4177; fax: +61 2 4634 4190.
    • ,
  • Gilbert Whitton

      Affiliations

    • Drug Health Services, Sydney South West Area Health Service, Australia
    • Tel.: +61 2 9722 8293; fax: +61 2 9722 8959.
    • ,
  • Toby Lea

      Affiliations

    • Drug Health Services, Sydney South West Area Health Service, Australia
    • Tel.: + 61 2 9378 1314; fax: +61 2 9378 1338.

Received 2 July 2007 ,Accepted 11 November 2007.

References 

  1. Bell J, Burrell T, Indig D, Gilmour S. Cycling in and out of treatment; participation in methadone treatment in NSW 1990–2002. Drug and Alcohol Dependence. 2006;81:55–61
  2. Cagle HH, Fisher DG, Senter TP, Thurmond RD, Kastar AJ. Classifying skin lesions of injection drug users: (SMA) 02-3753. Rockville, MD: SAMHSA; 2002;
  3. Darke S. Self-report among injecting drug users: A review. Drug and Alcohol Dependence. 1998;51:253–263
  4. Darke S, Ross J, Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug and Alcohol Dependence. 2001;62:77–82
  5. Department of Health . Drug misuse and dependence: Guidelines on clinical management. London: The Stationery Office; 1999;
  6. Jain R, Triapthi BM, Varghese ST, Kumar N, Kumar M. Can you trust self-reports among injectable drug users in clinical setting?. Journal of Substance Use. 2006;11:431–436
  7. NSW Department of Health . New South Wales opioid treatment program clinical guidelines for methadone and buprenorphine treatment of opioid dependence. Sydney: NSW Department of Health; 2006;
  8. Partanen TM, Rissanen A. Insulin injection practices. Practical Diabetes International. 2000;17:252–254
  9. Rhodes T, Stoneman A, Hope V, Hunt N, Martin A, Judd A. Groin injecting in the context of crack cocaine and homelessness: From ‘risk boundary’ to ‘acceptable risk’?. International Journal of Drug Policy. 2006;17:164–170
  10. Roszler MH, McCarroll KA, Donovan KR, Rashid T, Kling GA. The groin hit: Complications of intravenous drug abuse. Radiographics. 1989;9:487–508
  11. Seyoum B, Abdulkadir J. Systematic inspection of insulin injection sites for local complications related to incorrect injection technique. Tropical Doctor. 1996;26:159–161
  12. Vollum DI. Skin lesions in drug addicts. British Medical Journal. 1970;2:647–650
  13. Winstock, A.R., & Bell, J. (2006). Clinical guidelines assessing suitability for unsupervised medication doses for treating opioid dependency: Royal Australasian College of Physicians and Australasian Chapter of Addiction Medicine.
  14. Woodburn KR, Murie JA. Vascular complications of injecting drug misuse. British Jourrnal of Surgery. 1996;83:1329–1334
  15. Young RJ, Steel JM, Frier BM, Duncan LJ. Insulin injection sites in diabetes—A neglected area?. BMJ. 1981;283:349

PII: S0955-3959(07)00220-4

doi: 10.1016/j.drugpo.2007.11.002

International Journal of Drug Policy
Volume 20, Issue 1 , Pages 85-89 , January 2009

Article Tools